Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > Incoming

Bullboard Posts

Comment by Moemoney42on Oct 21, 2020 1:07pm

131 Views

Post# 31755616

RE:Incoming

Poor ol Wacko4505... he tries so hard to be relevant.. but fails miserably every time.. LOL..!

Waco4505 wrote: Halt incoming

Waco4505 (111)

August 25, 2020 - 04:57 PM

70 Reads

Post# 31452400

RE:Thank you

Hope you sold because it will go back to .25

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading

BMO evolves InvestorLine with enhanced tools for options trading

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity

Visionstate set to leverage success in the U.S. market

Visionstate set to leverage success in the U.S. market

Debt-free cannabis company set for next stage of growth

Debt-free cannabis company set for next stage of growth